Literature DB >> 1421692

E-cadherin expression: a counterbalance for cancer cell invasion.

M Mareel1, K Vleminckx, S Vermeulen, M Bracke, F Van Roy.   

Abstract

Invasion, eventually leading to metastasis, is presented as the result of a balance between the activation of 2 sets of genes, coined i+ (invasion promotor) and i- (invasion suppressor) genes. Experiments in vitro have indicated that the homotypic homophilic epithelial cell--cell adhesion molecule E-cadherin (L-CAM; uvomorulin; cell CAM 120/80; Arc-1; rrl antigen) is an i- gene product. In several cell families, manipulation of E-cadherin at the level of the protein by antibody-mediated inactivation, at the level of the mRNA by antisense DNA transfection, and at the level of the genome by sense DNA transfection respectively resulted in induction and suppression of invasiveness. Nude mouse tumors from non-invasive homogeneously E-cadherin-positive cell populations were found to be invasive and metastatic. These tumors expressed E-cadherin in a heterogeneous manner, the undifferentiated cells being negative; but tumor-derived cells in culture were again E-cadherin-positive, indicating downregulation of this protein by host factors. Several types of human cancers showed a similar heterogeneity suggesting a relationship between downregulation of E-cadherin and invasion. Our current research focus is on the factors responsible for E-cadherin downregulation in experimental and human cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421692

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  13 in total

Review 1.  Molecular genetics of prostate cancer: clinical applications.

Authors:  R A Morton; W B Isaacs
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

Review 2.  Molecular biology of cadherins in the nervous system.

Authors:  A M Dalseg; H Gaardsvoll; E Bock
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 3.  Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin.

Authors:  M Mareel; M Bracke; F Van Roy
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

Review 4.  Colorectal cancer: genetics of development and metastasis.

Authors:  Tetsuji Takayama; Koji Miyanishi; Tsuyoshi Hayashi; Yasushi Sato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

5.  Expression of E-cadherin adhesion molecule in vocal cord carcinomas.

Authors:  M Liu; G Lawson; M Delos; J Jamart; M Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

6.  Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.

Authors:  Xiaolong Wei; David Dombkowski; Katia Meirelles; Rafael Pieretti-Vanmarcke; Paul P Szotek; Henry L Chang; Frederic I Preffer; Peter R Mueller; Jose Teixeira; David T MacLaughlin; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-15       Impact factor: 11.205

7.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.

Authors:  T Bailey; L Biddlestone; N Shepherd; H Barr; P Warner; J Jankowski
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 8.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

9.  Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines.

Authors:  A R Kinsella; G C Lepts; C L Hill; M Jones
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

10.  Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.

Authors:  M E Bracke; B M Vyncke; E A Bruyneel; S J Vermeulen; G K De Bruyne; N A Van Larebeke; K Vleminckx; F M Van Roy; M M Mareel
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.